In 2020, Fresenius Medical Care North America, one of the nation’s leading healthcare conglomerates, made the decision to formally merge two of their most successful and synergistic companies, National Cardiovascular Partners (NCP) and Azura Vascular Care (Azura). By joining forces, this newly formed organization will become one of the largest ASC networks of outpatient facilities and physician practices in the US. The new company is in the midst of fully integrating and rebranding itself, so stay tuned for more details. In the meantime, we’d like to tell you a bit about who we are and what we do.
Azura operates and manages more than 60 outpatient vascular and ambulatory surgery centers (ASC) across the US. The company employs close to 1,200 people and performed more than 140,000 outpatient procedures in 2020 alone. Azura’s outpatient centers specialize in minimally invasive techniques to treat a wide range of vascular conditions, including:
NCP is the pioneer and creator of the outpatient hybrid (ASC & office-based lab) cardiovascular center model, and strives to be the highest-quality and largest outpatient cardiology and vascular services provider in the US. Since its inception in 2006, NCP has partnered with hundreds of the nation’s top physicians and performed more than 160,000 successful, outpatient cardiovascular procedures including:
The merger of Azura and NCP creates an outpatient network of more than 90 outpatient centers and physician practices in more than 25 states; focusing on developing one cohesive team that offers practice management, and a full range of advanced outpatient procedures to ensure a continuum of high quality and convenient patient care.
With specialties and procedures migrating to an outpatient setting every year, this is an exciting time for both Azura/NCP and the patients we serve. To learn more about us, please visit us at www.azuravascularcare.com and www.ncplp.com.
Procedures are shifting to surgery centers, but adding the cases is not for the faint of heart. The movement of cardiovascular care from hospitals to freestanding surgery centers is being driven by reimbursement trends, forward-thinking facilities and the steady beat of progress. The fledging service line is packed with promise — and plenty of questions that need to be answered.
In the face of the early days of the pandemic, Waco Cardiology Cath Lab worked to procure sufficient PPE and workflows that would allow safe handling of an influx of patients. Read their story to learn how they realized a > 20% increase in the number of CV cases in the second quarter of 2020 and held the volume steady.
NCP’s Chief Clinical Officer, Kelly Bemis, discusses how the 2020 addition of cardiac interventional codes to CMS's list of covered procedures is a game-changer for the industry and goes into detail about what it would take to add this service line to existing ASC facilities.
National Cardiovascular Partners Joins Forces with Two Cardiac Enterprises in Phoenix
National Cardiovascular Partners and Mesa Cardiovascular Research Center Join Forces to Elevate Outpatient Cardiovascular Care in Arizona